Tokyo, Nov. 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059613) titled 'A study to investigate outcomes in patients with ovarian, fallopian tube, or peritoneal cancer who underwent bowel surgery' on Nov. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Niigata University
Condition:
Condition - Stage II-IV ovarian, fallopian tube, or peritoneal cancer
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - To prospectively investigate the clinical significance of mesenteric lymph node metastasis in patients undergoing rectosigmoid resection for ovarian, fallopian tube, or peritoneal cancer
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Female
Key inclusion criteria - 1. Patients who underwent surgery at Niigata University Medical and Dental Hospital or Niigata Cancer Center Hospital
2. Age: 18-100 years
3. Diagnosed with Stage II-IV ovarian, fallopian tube, or peritoneal cancer
4. Including patients who underwent diagnostic laparoscopy only
5. Provided written informed consent
Key exclusion criteria - Cases judged inappropriate for study registration by the principal investigator
Target Size - 250
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 10 Month 30 Day
Date of IRB - 2025 Year 10 Month 29 Day
Anticipated trial start date - 2025 Year 11 Month 01 Day
Last follow-up date - 2036 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068106
Disclaimer: Curated by HT Syndication.
